Immune Checkpoint Inhibition in Prostate Cancer

被引：14
|
作者：
Nicholson, Lowell Thorndike [1 ]
Fong, Lawrence [2 ]
机构：
[1] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Div Hematol & Oncol, San Francisco, CA 94143 USA
来源：
TRENDS IN CANCER | 2020年 / 6卷 / 03期
关键词：
DOUBLE-BLIND; IPILIMUMAB; PLACEBO; SAFETY; TUMORS;
D O I：
10.1016/j.trecan.2020.01.003
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Although immunotherapy has proved to be effective in a variety of cancer subtypes, the role of immune checkpoint inhibition in the treatment of prostate cancer remains unclear. Here we review results from the latest clinical trials and discuss data suggesting that certain genetic mutations may confer increased sensitivity to immune checkpoint blockade.
引用
收藏
页码：174 / 177
页数：5
相关论文
共 50 条
  • [1] Immune Checkpoint Therapies in Prostate Cancer
    Goswami, Sangeeta
    Aparicio, Ana
    Subudhi, Sumit K.
    [J]. CANCER JOURNAL, 2016, 22 (02): : 117 - 120
  • [2] Immune Checkpoint Inhibitors in Prostate Cancer
    Venkatachalam, Shobi
    McFarland, Taylor R.
    Agarwal, Neeraj
    Swami, Umang
    [J]. CANCERS, 2021, 13 (09)
  • [3] Immune checkpoint inhibition in ovarian cancer
    Hamanishi, Junzo
    Mandai, Masaki
    Konishi, Ikuo
    [J]. INTERNATIONAL IMMUNOLOGY, 2016, 28 (07) : 339 - 348
  • [4] Autophagy inhibition by targeting PIKfyve potentiates response to immune checkpoint blockade in prostate cancer
    Qiao, Yuanyuan
    Choi, Jae Eun
    Tien, Jean C.
    Simko, Stephanie A.
    Rajendiran, Thekkelnaycke
    Vo, Josh N.
    Delekta, Andrew D.
    Wang, Lisha
    Xiao, Lanbo
    Hodge, Nathan B.
    Desai, Parth
    Mendoza, Sergio
    Juckette, Kristin
    Xu, Alice
    Soni, Tanu
    Su, Fengyun
    Wang, Rui
    Cao, Xuhong
    Yu, Jiali
    Kryczek, Ilona
    Wang, Xiao-Ming
    Wang, Xiaoju
    Siddiqui, Javed
    Wang, Zhen
    Bernard, Amelie
    Fernandez-Salas, Ester
    Navone, Nora M.
    Ellison, Stephanie J.
    Ding, Ke
    Eskelinen, Eeva-Liisa
    Heath, Elisabeth I.
    Klionsky, Daniel J.
    Zou, Weiping
    Chinnaiyan, Arul M.
    [J]. NATURE CANCER, 2021, 2 (09) : 978 - +
  • [5] Autophagy inhibition by targeting PIKfyve potentiates response to immune checkpoint blockade in prostate cancer
    Yuanyuan Qiao
    Jae Eun Choi
    Jean C. Tien
    Stephanie A. Simko
    Thekkelnaycke Rajendiran
    Josh N. Vo
    Andrew D. Delekta
    Lisha Wang
    Lanbo Xiao
    Nathan B. Hodge
    Parth Desai
    Sergio Mendoza
    Kristin Juckette
    Alice Xu
    Tanu Soni
    Fengyun Su
    Rui Wang
    Xuhong Cao
    Jiali Yu
    Ilona Kryczek
    Xiao-Ming Wang
    Xiaoju Wang
    Javed Siddiqui
    Zhen Wang
    Amélie Bernard
    Ester Fernandez-Salas
    Nora M. Navone
    Stephanie J. Ellison
    Ke Ding
    Eeva-Liisa Eskelinen
    Elisabeth I. Heath
    Daniel J. Klionsky
    Weiping Zou
    Arul M. Chinnaiyan
    [J]. Nature Cancer, 2021, 2 : 978 - 993
  • [6] The role of immune checkpoint inhibitors in prostate cancer
    Surdacki, Gabriel
    Szudy-Szczyrek, Aneta
    Goracy, Aneta
    Chyl-Surdacka, Katarzyna
    Hus, Marek
    [J]. ANNALS OF AGRICULTURAL AND ENVIRONMENTAL MEDICINE, 2019, 26 (01) : 120 - 124
  • [7] Immune Checkpoint Inhibition in the Treatment of Gynecologic Cancer
    Kristen Anderson
    Ramez N. Eskander
    [J]. Current Obstetrics and Gynecology Reports, 2018, 7 (1) : 6 - 19
  • [8] Immune Checkpoint Inhibition in Metastatic Urothelial Cancer
    Powles, Tom
    Smith, Kate
    Stenzl, Arnulf
    Bedke, Jens
    [J]. EUROPEAN UROLOGY, 2017, 72 (04) : 477 - 481
  • [9] Immune Checkpoint Inhibition in the Treatment of Gynecologic Cancer
    Anderson, Kristen
    Eskander, Ramez N.
    [J]. CURRENT OBSTETRICS AND GYNECOLOGY REPORTS, 2018, 7 (01): : 6 - 19
  • [10] Immune Checkpoint Inhibition in Head and Neck Cancer
    Forster, Martin David
    Devlin, Michael-John
    [J]. FRONTIERS IN ONCOLOGY, 2018, 8
12345